AlphaCrest Capital Management’s AMN Healthcare AMN Stock Holding History

AlphaCrest Capital Management’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,247	Closed	-$980K	–	70
2022 Q3	$980K	Buy	9,247 +824	+10%	+$90.3K	0.06%	626
2022 Q2	$924K	Buy	8,423 +1,688	+25%	+$167K	0.04%	694
2022 Q1	$703K	Sell	6,735 -245	-4%	-$25.4K	0.04%	728
2021 Q4	$854K	Buy	6,980 +2,976	+74%	+$330K	0.03%	871
2021 Q3	$459K	Sell	4,004 -1,481	-27%	-$157K	0.02%	955
2021 Q2	$532K	Buy	+5,485	New	+$476K	0.02%	939
2020 Q3	–	Sell	-8,350	Closed	-$378K	–	1079
2020 Q2	$378K	Buy	+8,350	New	+$399K	0.06%	515
2020 Q1	–	Sell	-4,134	Closed	-$258K	–	1008
2019 Q4	$258K	Buy	+4,134	New	+$244K	0.02%	1134
2019 Q3	–	Sell	-11,971	Closed	-$649K	–	1246
2019 Q2	$649K	Buy	11,971 +6,400	+115%	+$325K	0.06%	592
2019 Q1	$262K	Buy	+5,571	New	+$309K	0.04%	699

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AlphaCrest Capital Management's AMN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of AMN Healthcare (AMN) in Q4 2022, closing a stake of 9,247 shares — an estimated $980K sold.

AlphaCrest Capital Management first reported a position in AMN in Q1 2019 and held it in 10 quarters. The position peaked at $980K in Q3 2022. 483 funds tracked by Wall St. Rank hold AMN as of Q4 2022.

AlphaCrest Capital Management reported no remaining AMN Healthcare position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 9,247 AMN Healthcare shares in Q4 2022, an estimated $980K.
AlphaCrest Capital Management first reported a position in AMN Healthcare in Q1 2019 and held it in 10 quarters.
AlphaCrest Capital Management's AMN Healthcare position peaked at $980K in Q3 2022.
483 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.